United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$299Mraised across 5 rounds since 2013, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
No investor was named in the report.
From a historical funding record
Venrock
RA Capital Management
F-Prime Capital
Sofinnova Investments
Vivo Capital
KKR
Rock Springs Capital
Lilly VenturesFrom a historical funding recordSEC filing: $56M sold, first sale May 2014
No investor was named in the report.
Reported by sec.govSEC filing: $28M sold, first sale Jul 2013
From Coherus Biosciences's own website and the SEC filings it signed: 10 on the team.
On the board, as filediAugust J. TroendleChristos Bryan RichardsJames I. HealyMary T. SzelaV. Bryan Lawlis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
VenrockRA Capital ManagementVivo Capital
Eight Roads VenturesF-Prime CapitalSofinnova InvestmentsKKRFidelity BiosciencesRock Springs CapitalLilly VenturesMissing a round, or an investor who was in one? Tell us.
Coherus Biosciences's investors include Venrock, RA Capital Management, Vivo Capital, Eight Roads Ventures and F-Prime Capital, and 7 more on record.
Coherus Biosciences has raised $299M across 5 rounds since 2013.
Coherus Biosciences's most recent round was an Undisclosed round of $50M in Feb 2026.
Coherus Biosciences's largest round on record is $120M (Undisclosed round), in Apr 2015.
Coherus Biosciences's first round on record, in Jan 2013, was backed by Helix Ventures.
Coherus Biosciences's latest named round is an Undisclosed round, in Feb 2026.
Coherus Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
